Quintiles shuts Indian Phase I facility amid 'challenging environment'
This article was originally published in Scrip
Executive Summary
Quintiles has shut down its 86-bed Phase I clinical research unit in Hyderabad due to what it termed a "challenging external business environment", though the action is not being seen as part of any major scale-down in India by the international pharmaceutical research services company.